Delirium, Dementia, Amnestic, Cognitive Disorders  >>  epothilone D (BMS-241027)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epothilone D (BMS-241027) / BMS
NCT01492374: Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease

Completed
1
40
US, Canada, Europe
BMS-241027, Placebo matching BMS-241027
Bristol-Myers Squibb
Alzheimer's Disease
10/13
10/13

Download Options